- Home
- CMPX vs EMD Comparison
CMPX vs EMD Comparison
Compare CMPX & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- EMD
- Stock Information
- Founded
- CMPX 2014
- EMD 2003
- Country
- CMPX United States
- EMD United States
- Employees
- CMPX N/A
- EMD N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- EMD Finance/Investors Services
- Sector
- CMPX Health Care
- EMD Finance
- Exchange
- CMPX Nasdaq
- EMD Nasdaq
- Market Cap
- CMPX 576.5M
- EMD 604.6M
- IPO Year
- CMPX N/A
- EMD N/A
- Fundamental
- Price
- CMPX $3.65
- EMD $10.31
- Analyst Decision
- CMPX Strong Buy
- EMD
- Analyst Count
- CMPX 7
- EMD 0
- Target Price
- CMPX $14.71
- EMD N/A
- AVG Volume (30 Days)
- CMPX 1.7M
- EMD 248.5K
- Earning Date
- CMPX 11-11-2025
- EMD 01-01-0001
- Dividend Yield
- CMPX N/A
- EMD 10.25%
- EPS Growth
- CMPX N/A
- EMD N/A
- EPS
- CMPX N/A
- EMD N/A
- Revenue
- CMPX N/A
- EMD N/A
- Revenue This Year
- CMPX N/A
- EMD N/A
- Revenue Next Year
- CMPX N/A
- EMD N/A
- P/E Ratio
- CMPX N/A
- EMD N/A
- Revenue Growth
- CMPX N/A
- EMD N/A
- 52 Week Low
- CMPX $1.27
- EMD $7.85
- 52 Week High
- CMPX $4.08
- EMD $9.55
- Technical
- Relative Strength Index (RSI)
- CMPX 56.88
- EMD 48.50
- Support Level
- CMPX $3.31
- EMD $10.21
- Resistance Level
- CMPX $3.80
- EMD $10.50
- Average True Range (ATR)
- CMPX 0.24
- EMD 0.12
- MACD
- CMPX -0.01
- EMD -0.01
- Stochastic Oscillator
- CMPX 70.51
- EMD 36.36
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.